Pharmacological screening of analgesic activityBiswash Sapkota
1. The document describes several screening methods used to evaluate potential analgesic agents, including in vivo models using thermal, electrical, or chemical stimuli to induce pain states in animals, as well as in vitro receptor binding assays.
2. Common in vivo models discussed are the hot plate test, tail flick test, writhing test induced by acetic acid injection, and formalin test, which create persistent pain.
3. Details are provided on procedures for these tests, which involve administering a potential analgesic and measuring its ability to delay pain-induced responses like paw licking or jumping.
This document summarizes screening methods used to test antipyretic drugs. It describes the yeast-induced pyrexia method in rats, where yeast is injected to induce fever and test drugs are administered to lower temperature. It also discusses testing antipyretic activity of Bauhinia racemose and Gracilaria corticata extracts in rats, and testing in rabbits where fever is induced by yeast or lipopolysaccharides. Rectal temperatures are measured before and after drug administration to evaluate antipyretic effects.
1) The document discusses various in vitro and in vivo models used to study immunomodulatory activity, including inhibition of histamine release from mast cells, lymphocyte proliferation assays, and animal models of autoimmune diseases and hypersensitivity reactions.
2) Test protocols are provided for studying immunomodulation using assays such as mixed lymphocyte reactions, lymphocyte stimulation and cytokine production.
3) Animal models described include adjuvant-induced arthritis in rats and various spontaneous autoimmune disease models in mice and other species. Standard protocols are given for evaluating compounds in these disease models.
This document provides an overview of screening methods for analgesic drugs. It discusses various in vivo and in vitro methods used to screen analgesics, including pain-state models using thermal, mechanical, electrical, and chemical stimuli in animals. Specific in vivo models described are the tail-flick test, hot-plate test, acetic acid-induced writhing test, and various electrical and chemical stimulation tests. In vitro methods discussed include bioassays using isolated tissues to study nociceptin receptors, radioligand binding assays like 3H-naloxone binding to study opioid agonists/antagonists, and inhibition of enkephalinase as a screening method.
This document summarizes screening methods for evaluating potential anti-inflammatory drugs. It discusses the inflammatory response and various animal models used to test drug candidates, including carrageenan-induced paw edema, cotton pellet-induced granuloma, and UVB-induced erythema in guinea pigs. Several in vitro assays are also described, such as measuring COX inhibition and evaluating the ability of drugs to block mast cell degranulation and platelet-neutrophil adhesion. The goal of these screening methods is to effectively identify drug candidates that can target different phases and components of the inflammatory process.
The document describes several screening models used to evaluate the effects of drugs on behavioral and muscle coordination in animals. It discusses tests such as the open field test, hole board test, chimney test, grip strength, and rota rod method. These tests measure parameters like locomotor activity, exploration, muscle strength, and motor coordination. The results of these tests can provide information about a drug's effects and allow the calculation of values like ED50 doses for sedative, stimulant, and muscle relaxant drugs.
This document describes various in vivo and in vitro models used to study antihypertensive and vasodilator drugs. In vivo models include the Goldblatt hypertension model in rats, chronic renal hypertension in rats and dogs, and the tail cuff method in rats. In vitro models include ACE inhibition in guinea pig ileum and β1 sympatholytic activity in guinea pig atria. The document also provides details of the procedures for these models.
Pharmacological screening of analgesic activityBiswash Sapkota
1. The document describes several screening methods used to evaluate potential analgesic agents, including in vivo models using thermal, electrical, or chemical stimuli to induce pain states in animals, as well as in vitro receptor binding assays.
2. Common in vivo models discussed are the hot plate test, tail flick test, writhing test induced by acetic acid injection, and formalin test, which create persistent pain.
3. Details are provided on procedures for these tests, which involve administering a potential analgesic and measuring its ability to delay pain-induced responses like paw licking or jumping.
This document summarizes screening methods used to test antipyretic drugs. It describes the yeast-induced pyrexia method in rats, where yeast is injected to induce fever and test drugs are administered to lower temperature. It also discusses testing antipyretic activity of Bauhinia racemose and Gracilaria corticata extracts in rats, and testing in rabbits where fever is induced by yeast or lipopolysaccharides. Rectal temperatures are measured before and after drug administration to evaluate antipyretic effects.
1) The document discusses various in vitro and in vivo models used to study immunomodulatory activity, including inhibition of histamine release from mast cells, lymphocyte proliferation assays, and animal models of autoimmune diseases and hypersensitivity reactions.
2) Test protocols are provided for studying immunomodulation using assays such as mixed lymphocyte reactions, lymphocyte stimulation and cytokine production.
3) Animal models described include adjuvant-induced arthritis in rats and various spontaneous autoimmune disease models in mice and other species. Standard protocols are given for evaluating compounds in these disease models.
This document provides an overview of screening methods for analgesic drugs. It discusses various in vivo and in vitro methods used to screen analgesics, including pain-state models using thermal, mechanical, electrical, and chemical stimuli in animals. Specific in vivo models described are the tail-flick test, hot-plate test, acetic acid-induced writhing test, and various electrical and chemical stimulation tests. In vitro methods discussed include bioassays using isolated tissues to study nociceptin receptors, radioligand binding assays like 3H-naloxone binding to study opioid agonists/antagonists, and inhibition of enkephalinase as a screening method.
This document summarizes screening methods for evaluating potential anti-inflammatory drugs. It discusses the inflammatory response and various animal models used to test drug candidates, including carrageenan-induced paw edema, cotton pellet-induced granuloma, and UVB-induced erythema in guinea pigs. Several in vitro assays are also described, such as measuring COX inhibition and evaluating the ability of drugs to block mast cell degranulation and platelet-neutrophil adhesion. The goal of these screening methods is to effectively identify drug candidates that can target different phases and components of the inflammatory process.
The document describes several screening models used to evaluate the effects of drugs on behavioral and muscle coordination in animals. It discusses tests such as the open field test, hole board test, chimney test, grip strength, and rota rod method. These tests measure parameters like locomotor activity, exploration, muscle strength, and motor coordination. The results of these tests can provide information about a drug's effects and allow the calculation of values like ED50 doses for sedative, stimulant, and muscle relaxant drugs.
This document describes various in vivo and in vitro models used to study antihypertensive and vasodilator drugs. In vivo models include the Goldblatt hypertension model in rats, chronic renal hypertension in rats and dogs, and the tail cuff method in rats. In vitro models include ACE inhibition in guinea pig ileum and β1 sympatholytic activity in guinea pig atria. The document also provides details of the procedures for these models.
This document summarizes various animal models used to screen analgesics for acute and chronic pain. It describes models using thermal, electrical, chemical, and mechanical stimuli to induce nociception. For acute pain, it details hot plate, tail flick, and formalin tests. For chronic pain, it outlines neuropathic pain models like sciatic nerve injury and vincristine-induced neuropathy. Cancer and diabetic neuropathy models are also summarized. The document provides details of procedures, pain behaviors measured, and usefulness of each model in evaluating different classes of analgesics.
In this slide contains diabetics, classification, symptoms, complication, invivo and invitro screening models of anti diabetics.
Presented by: GEETHANJALI ADAPALA (Department of pharmacology).
RIPER, anantapur
This document discusses various methods for evaluating anti-asthmatic drugs, including both in vitro and in vivo methods. It provides details on common animal models and techniques used. Some key points:
- Asthma is a global health problem affecting 7-10% of the world's population. It is characterized by airway inflammation, obstruction, and hyperresponsiveness.
- Both acute toxicity tests in mice and various assays evaluating effects on isolated organs, cells, and receptors are used to initially screen potential anti-asthmatic drugs in vitro.
- Popular in vivo models include measuring bronchospasm in guinea pigs and studying effects on histamine-induced bronchoconstriction, arachidonic acid responses,
Screening methods for anti-anginal agents include in vivo and in vitro models. In vivo models involve inducing ventricular failure in animals through repeated injections of plastic microspheres into the left ventricular artery. In vitro models screen agents using isolated tissues like heart muscle to assess effects on coronary blood flow, oxygen consumption, and mechanical activity. Common classifications of anti-anginal agents are nitrates, beta-blockers, calcium channel blockers, potassium channel openers, and others like dipyridamole and trimetazidine.
The document summarizes various methods for screening peptic ulcer drugs, including both in vitro and in vivo models. In vitro methods include assays that measure inhibition of H+/K+-ATPase, while common in vivo models in rats include the pylorus ligation model, ethanol-induced gastric lesions, acetic acid-induced gastric ulcers, and cysteamine-induced duodenal ulcers. The pylorus ligation model involves ligating the pylorus of rats for 6 hours to induce ulcers, after which ulcer severity is scored. Several other chemical models use agents like ethanol, acetic acid, or cysteamine to directly damage the stomach lining of rats.
This document describes several screening methods used to assess the effects of drugs on motor coordination and muscle function in mice. The methods include the open field test, hole board test, inclined plane test, vertical screen test, rotarod test, and chimney test. Each method is briefly described, including the purpose, apparatus used, procedures, and outcomes measured. The tests evaluate behaviors like locomotion, exploration and curiosity that can be altered by sedative or stimulant drugs.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
Screening models of antiepileptic and nootropic drugsHimikaRathi
This document provides information on various methods used to screen potential antiepileptic drugs. It discusses in vivo models like maximal electroshock induced seizures in mice, pentylenetetrazol induced convulsions, and strychnine induced convulsions. In vitro methods like receptor binding assays and electrical recordings from brain slices are also covered. Different types of induced seizures and animal models of epilepsy are described. The mechanisms of commonly used proconvulsant drugs like picrotoxin and mechanisms of action of antiepileptic drugs are briefly discussed. Various stages of the kindling model are defined.
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxTUSHARUNDHAD3
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
1.INTRODUCTION
2.LIPOPROTEIN
3.RISK FACTORS
4.DIETARY SOURCE OF 5.CHOLESTEROL
6.CLASSIFICATION OF ANTIHYPERLIPIDEMIC AGENT
7.SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT
(A) In Vivo Models:
1.Triton induced hyperlipidemia in Wistar rat
2.Cholesterol diet induced atherosclerosis in rabbits (High fat diet)
3.Hereditary hyperlipidemia in rabbits
4.Hypolipidemic activity in Syrian hamsters
5.Transgenic animal model
6.Hereditary hypercholesteremia in rats
7. IV lipid tolerance test in rat
8.Efect of HMG COA reduction inhibition in vivo
9.Fructose induce hyperglycemia in rat
10.Cholestylamine binding
(B) In Vitro Models:
1.Inhibition of isolated HMG COA reductase inhibitors
2.ACAT inhibitory model
This document discusses various methods used to screen potential anti-arrhythmic drugs, including in vitro and in vivo models. In vitro models include the Langendorff technique using isolated guinea pig hearts. In vivo models include chemically induced arrhythmias using agents like aconitine in rats, electrically induced arrhythmias in dogs, exercise-induced ventricular fibrillation in dogs, and mechanically induced arrhythmias through coronary artery ligation in dogs. These animal models are used to evaluate the effects of test compounds on outcomes like heart rate, contractile force, incidence of arrhythmias, and mortality. While species differences exist, animal studies have helped advance the diagnosis and treatment of arrhythmias in humans.
Multiple sclerosis is a neurodegenerative disorder that affects the central nervous system including the brain, spinal cord, and optic nerves. There are several types of MS defined by their symptoms and progression. The pathophysiology involves the immune system mistakenly attacking the myelin sheath, resulting in plaques/lesions and disrupted nerve signaling. Potential causes include genetic and environmental factors. Several medications are used to treat MS symptoms or reduce immune attack. Screening methods include in vitro tests examining cells involved in MS and in vivo animal models that induce conditions resembling MS through viral infection, toxins, or experimental autoimmune encephalomyelitis.
The document discusses immunoassay of digoxin. It provides an overview of immunoassays including the basic principles of competitive and non-competitive immunoassays. It describes how digoxin works to treat conditions like congestive heart failure and its mechanisms of action. The document also outlines the procedure for performing an immunoassay to measure digoxin levels and lists several analytical methods used like enzyme immunoassay, cloned enzyme donor immunoassay, and fluorescence polarization immunoassay.
This document summarizes preclinical screening models of chronic obstructive pulmonary disease (COPD). It describes exposing mice to cigarette smoke over both acute (6 weeks) and chronic (5 days, 3 cigarettes/day) periods to model the effects of cigarette smoke, the main cause of COPD. For the acute study, mice are divided into groups exposed to air, smoke, or smoke with low- or high-dose test drugs. For the chronic study, groups are exposed to air, drugs and air, smoke, or smoke with low- or high-dose drugs. After exposure, the mice are sacrificed and their lungs examined to measure emphysema and macrophage volume as indicators of COPD pathology.
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
pre clinical Screening for anti asthmatic drugsDHINESHKUMAR V
This document describes various pre-clinical screening methods for anti-asthmatic drugs, including in vitro, isolated organ, and in vivo models. In vitro methods include the CULTEX technique using bronchial epithelial cell cultures and histamine receptor binding assays using guinea pig brain membranes. Tests in isolated organs involve measuring spasmolytic activity in guinea pig lung strips. In vivo models include tests in anesthetized guinea pigs to evaluate bronchospasmolytic effects and protection against anaphylactic shock or serotonin/histamine-induced asphyxia. Overall, the document outlines the most common pre-clinical tests used to evaluate potential anti-asthmatic effects prior to clinical trials.
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Preclinical studies involve testing drugs or treatments in animals before human trials. This document discusses various types of preclinical studies including in vitro, in vivo, in situ, and in silico experiments. It also describes methods to study immunomodulators including inhibition of histamine release from mast cells and mitogen-induced lymphocyte proliferation assays. Various in vivo models are outlined such as acute systemic anaphylaxis in rats and delayed type hypersensitivity tests.
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
This document describes various pharmacological screening techniques for analgesic agents. It discusses in vivo and in vitro models. In vivo models use thermal, electrical, mechanical, or chemical stimuli to induce pain in animals. Responses are measured before and after drug administration to test analgesic effects. Common in vivo models include the hot plate test, tail flick test, formalin test, and writhing test. In vitro models like receptor binding assays are also used to study mechanisms of analgesia. A variety of animal pain models exist to test treatments for both acute and chronic pain.
This document summarizes various animal models used to screen analgesics for acute and chronic pain. It describes models using thermal, electrical, chemical, and mechanical stimuli to induce nociception. For acute pain, it details hot plate, tail flick, and formalin tests. For chronic pain, it outlines neuropathic pain models like sciatic nerve injury and vincristine-induced neuropathy. Cancer and diabetic neuropathy models are also summarized. The document provides details of procedures, pain behaviors measured, and usefulness of each model in evaluating different classes of analgesics.
In this slide contains diabetics, classification, symptoms, complication, invivo and invitro screening models of anti diabetics.
Presented by: GEETHANJALI ADAPALA (Department of pharmacology).
RIPER, anantapur
This document discusses various methods for evaluating anti-asthmatic drugs, including both in vitro and in vivo methods. It provides details on common animal models and techniques used. Some key points:
- Asthma is a global health problem affecting 7-10% of the world's population. It is characterized by airway inflammation, obstruction, and hyperresponsiveness.
- Both acute toxicity tests in mice and various assays evaluating effects on isolated organs, cells, and receptors are used to initially screen potential anti-asthmatic drugs in vitro.
- Popular in vivo models include measuring bronchospasm in guinea pigs and studying effects on histamine-induced bronchoconstriction, arachidonic acid responses,
Screening methods for anti-anginal agents include in vivo and in vitro models. In vivo models involve inducing ventricular failure in animals through repeated injections of plastic microspheres into the left ventricular artery. In vitro models screen agents using isolated tissues like heart muscle to assess effects on coronary blood flow, oxygen consumption, and mechanical activity. Common classifications of anti-anginal agents are nitrates, beta-blockers, calcium channel blockers, potassium channel openers, and others like dipyridamole and trimetazidine.
The document summarizes various methods for screening peptic ulcer drugs, including both in vitro and in vivo models. In vitro methods include assays that measure inhibition of H+/K+-ATPase, while common in vivo models in rats include the pylorus ligation model, ethanol-induced gastric lesions, acetic acid-induced gastric ulcers, and cysteamine-induced duodenal ulcers. The pylorus ligation model involves ligating the pylorus of rats for 6 hours to induce ulcers, after which ulcer severity is scored. Several other chemical models use agents like ethanol, acetic acid, or cysteamine to directly damage the stomach lining of rats.
This document describes several screening methods used to assess the effects of drugs on motor coordination and muscle function in mice. The methods include the open field test, hole board test, inclined plane test, vertical screen test, rotarod test, and chimney test. Each method is briefly described, including the purpose, apparatus used, procedures, and outcomes measured. The tests evaluate behaviors like locomotion, exploration and curiosity that can be altered by sedative or stimulant drugs.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
Screening models of antiepileptic and nootropic drugsHimikaRathi
This document provides information on various methods used to screen potential antiepileptic drugs. It discusses in vivo models like maximal electroshock induced seizures in mice, pentylenetetrazol induced convulsions, and strychnine induced convulsions. In vitro methods like receptor binding assays and electrical recordings from brain slices are also covered. Different types of induced seizures and animal models of epilepsy are described. The mechanisms of commonly used proconvulsant drugs like picrotoxin and mechanisms of action of antiepileptic drugs are briefly discussed. Various stages of the kindling model are defined.
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxTUSHARUNDHAD3
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
1.INTRODUCTION
2.LIPOPROTEIN
3.RISK FACTORS
4.DIETARY SOURCE OF 5.CHOLESTEROL
6.CLASSIFICATION OF ANTIHYPERLIPIDEMIC AGENT
7.SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT
(A) In Vivo Models:
1.Triton induced hyperlipidemia in Wistar rat
2.Cholesterol diet induced atherosclerosis in rabbits (High fat diet)
3.Hereditary hyperlipidemia in rabbits
4.Hypolipidemic activity in Syrian hamsters
5.Transgenic animal model
6.Hereditary hypercholesteremia in rats
7. IV lipid tolerance test in rat
8.Efect of HMG COA reduction inhibition in vivo
9.Fructose induce hyperglycemia in rat
10.Cholestylamine binding
(B) In Vitro Models:
1.Inhibition of isolated HMG COA reductase inhibitors
2.ACAT inhibitory model
This document discusses various methods used to screen potential anti-arrhythmic drugs, including in vitro and in vivo models. In vitro models include the Langendorff technique using isolated guinea pig hearts. In vivo models include chemically induced arrhythmias using agents like aconitine in rats, electrically induced arrhythmias in dogs, exercise-induced ventricular fibrillation in dogs, and mechanically induced arrhythmias through coronary artery ligation in dogs. These animal models are used to evaluate the effects of test compounds on outcomes like heart rate, contractile force, incidence of arrhythmias, and mortality. While species differences exist, animal studies have helped advance the diagnosis and treatment of arrhythmias in humans.
Multiple sclerosis is a neurodegenerative disorder that affects the central nervous system including the brain, spinal cord, and optic nerves. There are several types of MS defined by their symptoms and progression. The pathophysiology involves the immune system mistakenly attacking the myelin sheath, resulting in plaques/lesions and disrupted nerve signaling. Potential causes include genetic and environmental factors. Several medications are used to treat MS symptoms or reduce immune attack. Screening methods include in vitro tests examining cells involved in MS and in vivo animal models that induce conditions resembling MS through viral infection, toxins, or experimental autoimmune encephalomyelitis.
The document discusses immunoassay of digoxin. It provides an overview of immunoassays including the basic principles of competitive and non-competitive immunoassays. It describes how digoxin works to treat conditions like congestive heart failure and its mechanisms of action. The document also outlines the procedure for performing an immunoassay to measure digoxin levels and lists several analytical methods used like enzyme immunoassay, cloned enzyme donor immunoassay, and fluorescence polarization immunoassay.
This document summarizes preclinical screening models of chronic obstructive pulmonary disease (COPD). It describes exposing mice to cigarette smoke over both acute (6 weeks) and chronic (5 days, 3 cigarettes/day) periods to model the effects of cigarette smoke, the main cause of COPD. For the acute study, mice are divided into groups exposed to air, smoke, or smoke with low- or high-dose test drugs. For the chronic study, groups are exposed to air, drugs and air, smoke, or smoke with low- or high-dose drugs. After exposure, the mice are sacrificed and their lungs examined to measure emphysema and macrophage volume as indicators of COPD pathology.
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
pre clinical Screening for anti asthmatic drugsDHINESHKUMAR V
This document describes various pre-clinical screening methods for anti-asthmatic drugs, including in vitro, isolated organ, and in vivo models. In vitro methods include the CULTEX technique using bronchial epithelial cell cultures and histamine receptor binding assays using guinea pig brain membranes. Tests in isolated organs involve measuring spasmolytic activity in guinea pig lung strips. In vivo models include tests in anesthetized guinea pigs to evaluate bronchospasmolytic effects and protection against anaphylactic shock or serotonin/histamine-induced asphyxia. Overall, the document outlines the most common pre-clinical tests used to evaluate potential anti-asthmatic effects prior to clinical trials.
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Preclinical studies involve testing drugs or treatments in animals before human trials. This document discusses various types of preclinical studies including in vitro, in vivo, in situ, and in silico experiments. It also describes methods to study immunomodulators including inhibition of histamine release from mast cells and mitogen-induced lymphocyte proliferation assays. Various in vivo models are outlined such as acute systemic anaphylaxis in rats and delayed type hypersensitivity tests.
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
This document describes various pharmacological screening techniques for analgesic agents. It discusses in vivo and in vitro models. In vivo models use thermal, electrical, mechanical, or chemical stimuli to induce pain in animals. Responses are measured before and after drug administration to test analgesic effects. Common in vivo models include the hot plate test, tail flick test, formalin test, and writhing test. In vitro models like receptor binding assays are also used to study mechanisms of analgesia. A variety of animal pain models exist to test treatments for both acute and chronic pain.
preclinical screening models for Analgesic drugs SachinGulia12
This document discusses various preclinical screening methods for analgesic drugs. It describes several in vivo animal models used to test analgesics, including thermal, electrical, chemical and mechanical stimulus-induced pain models. The hot plate, tail flick and tail immersion tests involve thermal stimuli. The tooth pulp stimulation and tail shock tests use electrical stimuli. The formalin and writhing tests employ chemical stimuli. Mechanical stimuli models include the tail clip and Randall Selitto tests. The models aim to evaluate potential analgesic drugs for their ability to prolong response latency and reduce pain-related behaviors like paw licking.
The document summarizes various in vivo and in vitro models used to test analgesic agents. Some key in vivo models discussed are the hot plate test, tail flick test, and writhing test, which assess analgesic effects using thermal, mechanical, and chemical stimuli respectively. Signs of pain in rodents and reasons for minimizing animal distress are also mentioned. The document also briefly outlines some in vitro models like receptor binding assays to study mechanisms of opioid, cannabinoid, and other analgesic agents.
Screening models diuretics and analgesicsRohitPal122
The document summarizes various in vivo and in vitro screening models used to test analgesics and diuretics. It describes several common in vivo models that use thermal, electrical or chemical stimuli to induce pain in mice or rats, such as the tail flick test, hot plate test, and formalin test. It provides details on procedures, evaluation methods, and principles of selected models, including the tail immersion test, grid shock test, and monkey shock titration test. The document also briefly mentions some in vitro models like receptor binding assays.
screening of analgesics & drugs used in arthritis & neuropathic painMeenakshi Gupta
This document discusses various in vivo and in vitro models used for screening analgesics, drugs used to treat arthritis, and neuropathic pain. For in vivo models, it describes techniques using thermal, mechanical, electrical, and chemical stimuli to induce pain states in animals and evaluate analgesic effects. These include the tail flick test, hot plate test, von Frey filaments, tooth pulp stimulation, formalin test, and acetic acid writhing. It also discusses models of neuropathic pain like the chronic constriction injury model and models of arthritis like the anterior cruciate ligament transection model in dogs. In vitro techniques described are radioligand binding assays to evaluate drug interactions with opioid receptors.
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsMADHAV JAJNURE
This document summarizes several common in vivo screening methods used to evaluate analgesics and anti-inflammatory agents. It describes tests such as the hot plate method, tail flick method, formalin test, and writhing test to assess analgesic activity. For anti-inflammatory activity, it outlines acute phase screens like carrageenan-induced paw edema in rats and chronic phase methods like cotton pellet-induced granuloma formation. The screening methods are used to determine drug properties and dosages needed for analgesic or anti-inflammatory effects.
This document provides an overview of analgesic models used to study pain and the effects of pain medications. It begins with definitions of pain, nociception, and classifications of acute and chronic pain. It then discusses various types of analgesics and how they are classified. The remainder of the document outlines several experimental animal models used to test analgesics, including thermal, mechanical, electrical, and chemical stimulus models. It also discusses in vitro assays and models of chronic pain conditions. In conclusion, the document provides an in-depth review of the major experimental models employed in analgesic research using animal subjects.
This document provides an overview of various screening methods for analgesics, including animal models and in vitro techniques. It describes models of acute, chronic, cancer, and neuropathic pain using thermal, electrical, chemical, and mechanical stimuli. Animal models involve tests like the hot plate test, tail flick test, formalin test, and Randall Selitto test. The document also discusses the roles of VIP, PACAP, and nociceptin in modulating pain and their potential as analgesic targets.
Screening models for central and peripheral analgesicskrishnabajgire
This document describes screening models used to test central and peripheral analgesic activity. For central analgesic activity, it discusses the hot plate test, grid-shock test, and tail immersion test which measure response latency to a painful stimulus. For peripheral analgesic activity, it discusses the writhing test which counts stretching behaviors in mice after an irritant injection, and the Randall-Selitto test which applies pressure to inflamed tissue in rats to measure pain threshold changes.
Anlalgesic activity and its classificationKOMAL AROOSH
Analgesics are medicines that are used to relieve pain. They are also known as painkillers or pain relievers. Technically, the term analgesic refers to a medication that provides relief from pain without putting you to sleep or making you lose consciousness.
Non-steroidal anti-inflammatory drugs, also known as NSAIDs are medicines that are used to relieve pain, and reduce swelling (inflammation). Examples include aspirin, naproxen, ibuprofen, diclofenac, and COX-2 inhibitors such as celecoxib and meloxicam.
This document provides an overview of preclinical screening and screening of analgesics. It discusses the types of preclinical studies, including short-term and long-term animal studies. It also describes the different types of screening, including simple, blind, and programmed screening. Several methods for screening analgesics are outlined, including various animal models like the hot plate method and formalin test, as well as in vitro models. The document provides details on the mechanism of action and types of analgesics.
This document describes various in vivo and in vitro screening methods used to evaluate potential analgesic compounds. Some key in vivo methods include the tail flick test, hot plate test, and acetic acid-induced writhing test, which assess analgesic effects using thermal, mechanical, and chemical pain stimuli, respectively. Important in vitro assays involve measuring the inhibition of nociceptin, binding to opioid receptors, and inhibition of enkephalinase enzyme. The screening methods aim to distinguish between narcotic and non-narcotic analgesics and help identify new compounds for treating different pain states.
This document summarizes pain physiology and the evaluation of analgesics. It discusses the definition of pain, pain pathways, endogenous opioid peptides, and types of analgesics. Methods for evaluating analgesics include in vitro tests like receptor binding assays and in vivo tests using various pain models in animals. Acute pain models include thermal, electrical, chemical and mechanical stimuli. Chronic pain models examine neuropathic pain and cancer pain. While no single model perfectly mimics human pain, animal models remain important for assessing analgesic drug activity.
Invivo screening methods for anti inflammatory agentsSravani Ganti
This document describes various in vivo screening methods used to test potential anti-inflammatory agents. It discusses acute, subacute, and chronic inflammation phases and associated screening methods. Methods described include carrageenan-induced paw edema in rats, croton-oil induced ear edema in mice, oxazolone induced ear edema in mice, UV erythema in guinea pigs, pleurisy test, granuloma pouch technique, and vascular permeability test. Each method involves inducing inflammation and measuring the ability of test compounds to reduce inflammatory responses like edema formation compared to control groups.
Similar to Drug Screening Methods of Analgesic agents (20)
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Drug Screening Methods of Analgesic agents
1. Drug screening methods of
Analgesic agents
Dr. Abhishek Y. Vyas
3rd year PG student
Department of Pharmacology
AMC MET Medical College
2. • Nociceptive component : disabling,
unpleasant sensation evoked by noxious
stimuli and conveyed to CNS by ascending
pathways
• Affective component : which is the
psychological response towards the pain
conveyed from CNS to dorsal horn by
descending pathways
7/15/2017 2
3.
4. Drug screening methods of Analgesic agents
1. Animal Models of Acute Pain
1. Models using thermal stimulus
1. Hot plate method
2. The tail-flick method
1. Radiant heat
2. Immersing of the tail
3. Cold flick test
2. Models using electrical stimulus
1. Tooth pulp test
2. Monkey shock titration tesat
3. Models using chemical stimulus
1. Formalin test
2. Writhing test
3. Other chemical compounds
4. Models using mechanical stimulus
1. Haffner’s tail clip method
2. Randall salitto test
2. Animal models of Chronic Pain
1. Neuropathic pain models
2. Vincristine-induced neuropathy model
3. Diabetic neuropathy model
3. Models of Cancer Pain
1. Rat model of Bone cancer pain
5. Animal models of acute pain
• Animal test used in the search for new analgesics are designed as models for treatment of
pathological pain in man. They measure the power of the drug to increase the minimal stimulus
required to elicit pain or nociceptive response.
Hot Plate Method
•Widely used to evaluate opioid analgesics
Mice weighing ~20 g are used
Placed on the hot plate which maintained T 55-56 ͦC
Response as jumping, withdrawal of paws & licking of paws
are seen
Time period of response is recorded
Test compound are administered oral or S/C and latency
period recorded after 20,60 & 90 min
Values are compared before and after drug administration by
t-test7/15/2017 5
6. The Tail-Flick Test
• This test is widely and reliably used for reveling potency of opioid analgesics. In this test heat is
used as noxious stimuli and causes a simple nociceptive spinal reflex response in which the rat or
mouse flick its tail away the heat source. This test is very useful for discrimination between
centrally acting morphine like analgesics and non opioid analgesics.
The Tail Flick Test Using Radiant Heat
Mice weighing 18-22 g are used and placed in small cage leaving tail exposed
Tail held gently by observer. Light beam is focused to proximal third of tail
The mouse tries to pull the tail away and rotates the head. This reaction knows as
“escape reaction”
Reaction time of movement recorded
Test drug and standard are administered orally or s/c
Same procedure repeated and reaction time recorded after 30, 60
and 120 min
Lengthening time of reaction is interpreted as an analgesic action of drug7/15/2017 6
7. The Tail-Flick test using immersion of the tail
Wistar rats weight 170-210 g are used
Placed in separate cages in such a way that their tail hangs out freely
Distal 5cm part of tail of marked which is immersed in cup filled with warm water (Temp
55 ͦC)
A tail withdrawal reflex is seen within seconds
This reaction time is recorded. Normal reaction time was 1-5 sec
Test drugs are given orally or s/c and reaction time was recorded after 0.5, 1,2,3,and 6 hrs
Centrally acting analgesic drugs are capable of prolongation of tail withdrawal reflex and
hence withdrawal time of more than 6 sec in test animals denotes positive analgesic
response of test drug
7/15/2017 7
8. Models using electrical stimulus
Tooth pulp test
Rabbits 2-3 kg used and anesthetized with thiopental IV
Using dental drill, tooth pulp chambers are exposed close to the two front incisors
Clamping electrodes are placed into the drilled holes
After 30 min, electrical stimulus is applied by rectangular current 50Hz upto 1 sec
Current is started with 0.2 mA and increased until animal started licking. Threshold is
determined at least 3 times in each animal
Test compound is administered orally or IV
After 15,30, 60 and 120 min threshold current is measured with prior to drug administration
7/15/2017 8
9. Monkey shock titration test
• This method is used for final evaluation of a new
compound having analgesic potential
The monkeys are seated on restraining chairs
By A Coulbourn Instrument Programmable Shocker
electrical current is delivered through electrodes
which are coupled to shaved portion of tail
The current ranges from 0-4 mA through 29 progressive
steps
The monkey press the bar to interrupt the shock and for
each monkey, a stable baseline shock level is
recorded
After 24 hrs drug is administered and shock titration
activity is measured according to change in
maximum level of median shock intensity for drug as
compared to control levels
7/15/2017 9
10. Models Using Chemical stimulus
• This tests involve administration of irritant, algogenic chemicals as nociceptive stimulus.
Chemical stimulation induces slow form of stimulus.
Formalin Test
• 10% formalin is used as chemical noxious stimulus
• By injecting formalin solution into the paw of a rat/mouse a model of persistent
pain caused by peripheral tissue injuries and inflammation is created.
• In this test, animals show two phases of nociceptive behavior involving two
different stimuli:
1. Early phase starts immediately after injection and lasts for 3-5 min
2. Late phase starts after 10-15 min and lasts for 20-40 min
• This is due to combination of an inflammatory reaction in peripheral tissue and
functional changes in dorsal horn of spinal cord.
• Opioids are antinociceptive for both phases while NSAIDs are more effective in
second phase.
7/15/2017 10
11. Wistar rats weighing 180-300 g are used
Dorsum of front paw injected with 0.05 ml of 10% formalin s/c
Animals placed in separate cages for observation of pain response in both phases
Responses are elevation or favoring of the paw or licking and biting of the paw
Scoring of pain was recorded as per pain scale
After administration of test drug again scoring is done with 30, 60 min for comparison
If both paws are allowed to rest on the floor this is taken as positive analgesic
response
7/15/2017 11
12. Writhing Test
• This model projects visceral or peritoneal pain in animal and useful to detect peripheral
analgesic activity of test compound.
Mice weighing 20-25 gm are used
Phenylquinon (0.002 %) is suspended in 1% suspension
of carboxy methylcellulose
An aliquot of 0.25 ml of suspension is injected
intraperitonially in each animal
The animal reacts with characteristic stretching behavior
series of constrictions occur that travel along the abdominal wall and accompanied by turning
movement of the body and extension of the hind limbs. This response is called as writhing
A group of animals is used as test group in which test drugs are administered before
Phenylquinon
Mice are placed in glass chamber and number of writhes are recorded for 10 min in each animal
7/15/2017 12
13. Models using mechanical stimulus
Haffner’s Tail Clip Method
• This method is highly sensitive for centrally acting drugs
• Preferred sites for stimulus are hind paw and the tail
Mice are used and artery clip is placed at the root of the tail to apply noxious stimulus
A quick response is seen as biting the clip or tail
Time between application of clip and response is recorded
Test compounds are administered and same procedure is repeated after 15,30 and 60 min
and reaction time is measured
Reaction time of the test animals grater than the cut off time denotes a positive response
indicating analgesic activity
7/15/2017 13
14. Randall Selitto Test
• The principle of this test is that inflammation increases the sensitivity to pain and
thus decreases pain threshold
• In this test inflammation is induced by s/c administration of Brewer’s yeast and
then pressure is applied, which increases the intensity of pain.
Wistar rats are divided in two groups and in test group test agents are administered
After 15-30 min 0.1ml Brewer’s yeast (20% suspension) in distilled water is injected s/c
in planter surface of the left hind paw
After 3hrs using Randall Selitto apparatus, pressure is applied on planter surface of
foot at constant rate until animal struggles or squeals
In both group each animal tested for its control pain threshold and comparison is
made between groups
7/15/2017 14
15. Animal models of Chronic Pain
• Partial somatosensory nerve injury is the cause of causalgiform pain disorder in man.
• Causalgia is characterized by spontaneous burning pain combained with hyperalgesia
and allodynia
Sprague Dawley rats are used and anesthetized with halothane. Local incision is given and
sciatic nerve of both legs are exposed at level of mid thigh
A sutures are tide loosely around right sciatic nerve and left is just mobilized
During next days animal show a mild aversion of affected paw and foot drop
The thermal nociceptive threshold of hind paw is measured in each animal
Rats are placed beneath a transparent plastic cage upon a glass plate such that a halogen
projector lamp could be placed below it. Lamp is focused at planter area of one hind
paw
As soon as heat exposure of heat is applied a withdrawal response of hind paw is seen
The time interval between the exposure of heat and response is measured in each animal
7/15/2017 15
16. After 7-8 days test drug and vehicle are injected intrathecally in test and control group
respectively
Paw withdrawal latency (PWL) of hind paws is recorded before and after 5,15,30, 60 and
90 min of drug administration.
PWL which was the maximum during the first 30 min after drug or vehicle injection is
called as maximum PWL
To evaluate hyperesthesia, the difference score (DC) is calculated by maximum PWL of
control side/maximum PWL of the affected side
7/15/2017 16
17. Vincristine-induced neuropathy model
• this method provides a good model for study of a painful peripheral neuropathies
in patients receiving vincristin as a chemotherapeutic agents
Vincristine is administered daily for 2 weeks in rats
A decreased noceceptive threshold and hyperalgesia occurs after second day of
administration
Chronic lowered threshold and increased response to stimuli is seen during second
week of vincristine administration
Responses gradually return to baseline following discontinuation of treatment
7/15/2017 17
18. Diabetic Neuropathy Model
• Painful diabetic neuropathy is on of the most common complication of IDD in man
• Streptozotocin induced (STZ) diabetic rat has been used for chronic pain with signs of
hyperalgesia and allodynia
STZ is administered in rats to develop DM
Different types of stimuli like mechanical, thermal and cold applied
Decreased reaction threshold to noxious heat stimuli and non painful thermal stimuli is
observed. This serves as evidence of hyperalgesia and allodynia
This reactions is observed after 2 weeks of establishment if DM
Kiguchi S et al evaluated antinociceptive effect of oxcarbazepine in diabetic neuropathy
rat model and suggested that oxcarbazepine has analgesic action in neuropathy
7/15/2017 18
19. Model of cancer pain
• Bone metastasis is one of the major causes of cancer related pain.
• In present model, bone cancer is induced in the rat by syngeneic MRMT-1 mammary
tumor cell line
Sprague Dawley rats are given intra tibial injection of syngeneic MRMT-1 carcinoma cells
Control rats received heat-killed cells vehicle
Those who received syngeneic MRMT-1 carcinoma cells, develop behavioral sign indicative
of pain: allodynia, difference of weight bearing between hind paws
No tumor growth was observed in heat-killed MRMT-1 injected animals
The general activity of these animal is not changed
7/15/2017 19